IRF3 and gastric carcinoma: Meanwhile, downregulation or overexpression of IRF3 in human gastric carcinoma cell lines BGC-823 (Supplementary Fig. S8a–c) and HGC-27 (Supplementary Fig. S8d–f) did not affect the Wnt target or associated genes expression upon wnt3a treatment.